Samar Alsafadi

Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

Samar Alsafadi, Alexandre Houy, Aude Battistella et al. · Nature Communications · 2016 · 373 citations · Full text

Tumor Biology, Cancer-associated Sf3b1 Mutations, Somatic Variant +9

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

Lynn Quek, Muriel D. David, Alison Kennedy et al. · Nature Medicine · 2018 · 193 citations · Full text

Hematological Malignancy, Clonal Heterogeneity, Medicine +11

Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

Virginie Quidville, Samar Alsafadi, Aïcha Goubar et al. · Cancer Research · 2013 · 101 citations

Cancer Cells Triggers, Cell Death, Cancer Biology +16

Splicing Patterns in <i>SF3B1</i> -Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes

Jérémy Bigot, Ana I. Lalanne, Francesca Lucibello et al. · Cancer Discovery · 2021 · 83 citations · Full text

A variant erythroferrone disrupts iron homeostasis in <i>SF3B1</i> -mutated myelodysplastic syndrome

Sabrina Bondu, Anne‐Sophie Alary, Carine Lefèvre et al. · Science Translational Medicine · 2019 · 80 citations · Full text